ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,820Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 161

$674K Total Retail Price of All Prescriptions

Rank: 13 out of 161

602 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
62% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 602 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

24% of this provider’s 602 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 12,076 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 4%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $85 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
SIMVASTATIN 800 595 1 2
AMLODIPINE BESYLATE 778 591 2 6
FUROSEMIDE 636 437 3 5
LISINOPRIL 608 458 4 3
HYDROCODONE-ACETAMINOPHEN 567 392 S3 5 1
OMEPRAZOLE 475 328 6 4
POTASSIUM CHLORIDE 453 344 7 9
METFORMIN HCL 450 284 8 19
LEVOTHYROXINE SODIUM 428 332 9 11
METOPROLOL TARTRATE 344 254 10 7
RANITIDINE HCL 306 127 11 38
TAMSULOSIN HCL 274 226 12 23
HYDROCHLOROTHIAZIDE 271 214 13 18
NEXIUM 271 169 13 22
GLIPIZIDE ER 244 199 15 94
ISOSORBIDE MONONITRATE ER 244 182 15 16
TRAMADOL HCL 216 151 17 28
NIFEDIPINE ER 212 138 18 83
ZOLPIDEM TARTRATE 201 153 19 20
METOPROLOL SUCCINATE 201 169 19 14
MELOXICAM 184 132 21 24
CARVEDILOL 176 141 22 8
PROAIR HFA 167 118 23 71
RAMIPRIL 166 124 24 72
CLOPIDOGREL 160 112 25 13
CLONIDINE HCL 156 105 26 44
LISINOPRIL-HYDROCHLOROTHIAZIDE 140 82 27 30
CYCLOBENZAPRINE HCL 139 66 R 28 53
PRAVASTATIN SODIUM 137 105 29 15
WARFARIN SODIUM 133 111 30 12
GABAPENTIN 127 85 31 10
ATENOLOL 127 83 31 26
ATORVASTATIN CALCIUM 123 114 33 21
CITALOPRAM HBR 121 83 34 29
LOSARTAN POTASSIUM 118 72 35 31
DIGOXIN 118 98 35 25
FLUTICASONE PROPIONATE 117 69 37 43
AMLODIPINE BESYLATE-BENAZEPRIL 116 116 38 112
SPIRONOLACTONE 115 71 39 57
TRIAMTERENE-HCTZ 112 54 40 55
NAPROXEN 112 53 40 162
DIOVAN 104 104 42 50
ESCITALOPRAM OXALATE 101 78 43 74
VENTOLIN HFA 99 68 44 122
METOCLOPRAMIDE HCL 98 82 45 88
PLAVIX 97 64 46 17
ADVAIR DISKUS 94 63 47 63
DONEPEZIL HCL 90 89 48 36
HYDRALAZINE HCL 86 70 49 141
ACETAMINOPHEN-CODEINE 79 44 S3 50 213
GLIPIZIDE XL 78 66 51 146
AMITRIPTYLINE HCL 77 46 R 52 45
GLIMEPIRIDE 75 32 53 113
SPIRIVA 73 48 54 32
DIOVAN HCT 69 59 55 65
CEFADROXIL 68 54 56 298
LANTUS 67 48 57 114
ALLOPURINOL 67 60 57 66
FINASTERIDE 65 65 59 64
SUCRALFATE 65 30 59 73
METFORMIN HCL ER 64 45 61 191
POLYETHYLENE GLYCOL 3350 63 61 62 61
JANUVIA 62 62 63 172
TIZANIDINE HCL 60 48 64 58
ENALAPRIL MALEATE 60 45 64 106
JANUMET 58 38 66 235
LOSARTAN-HYDROCHLOROTHIAZIDE 57 47 67 52
DILTIAZEM 24HR CD 57 49 67 180
MECLIZINE HCL 55 51 69 183
IBUPROFEN 55 32 69 243
COMBIVENT 54 30 71 181
DICLOFENAC SODIUM 53 49 72 223
KLOR-CON M20 53 39 72 103
ACTOS 53 33 72 331
ALENDRONATE SODIUM 53 41 72 68
VERAPAMIL ER 52 52 76 132
GLIPIZIDE 52 35 76 59
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 23, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.